| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.137 | 16.012 | 18.216 | 9.176 | 31.228 | 21.455 | 19.401 | 4.965 | 15.245 | 5.563 |
| Total Income - EUR | 15.938 | 13.581 | 19.457 | 14.813 | 33.367 | 23.172 | 16.799 | 6.840 | 12.287 | 3.836 |
| Total Expenses - EUR | 15.601 | 13.126 | 19.047 | 14.293 | 21.033 | 21.587 | 11.843 | 4.643 | 11.924 | 3.693 |
| Gross Profit/Loss - EUR | 337 | 456 | 410 | 519 | 12.334 | 1.584 | 4.955 | 2.197 | 363 | 143 |
| Net Profit/Loss - EUR | 31 | 135 | 228 | 425 | 12.014 | 1.387 | 4.761 | 2.052 | 305 | 121 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Editmed Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 2.440 | 2.138 | 2.613 | 2.091 |
| Current Assets | 3.254 | 2.159 | 4.511 | 5.680 | 13.465 | 15.568 | 17.147 | 19.182 | 18.472 | 19.652 |
| Inventories | 2.514 | 1.119 | 1.241 | 4.821 | 10.203 | 8.165 | 11.488 | 14.242 | 10.849 | 10.183 |
| Receivables | 442 | 862 | 3.256 | 832 | 1.305 | 1.731 | 1.934 | 3.521 | 3.176 | 4.947 |
| Cash | 299 | 178 | 13 | 27 | 1.958 | 5.672 | 3.724 | 1.419 | 4.447 | 4.523 |
| Shareholders Funds | 85 | 220 | 444 | 860 | 12.851 | 13.995 | 18.446 | 20.555 | 20.797 | 20.802 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.169 | 1.940 | 4.067 | 4.820 | 614 | 1.572 | 1.141 | 766 | 288 | 942 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2361 - 2361" | |||||||||
| CAEN Financial Year |
2361
|
|||||||||
Comments - Editmed Impex Srl